Literature DB >> 19017288

Clinico-pathologic findings in end-stage pediatric heart transplant grafts.

Gregory Perens1, Faqian Li, Scott Meier, Ravneet Kaur, Juan Carlos Alejos, Michael Fishbein.   

Abstract

The pathologic patterns existing in end-stage pediatric heart transplant grafts may help explain the symptoms and changes seen by echocardiography and angiography in these children. Retrospective chart review and pathologic study of explanted heart grafts was performed on 12 patients that had undergone 14 heart re-transplantations. Clinical status, echocardiographic and catheterization data at the time of transplantation were correlated to the pathologic findings. At re-OHT, eight were inpatients with heart failure symptoms and/or inotropic support requirements. Echocardiograms were abnormal in all prior to re-OHT with significant diastolic dysfunction, but LVEF >40% in all but one. There was significant epicardial fibrosis in all grafts, and all had severe CAV of epicardial arteries. However, intramyocardial coronary disease was mild in nine (64%) grafts. Moderate or severe interstitial fibrosis occurred in only three grafts, and in a perivascular distribution in eight. End-stage pediatric heart allografts have severe epicardial CAV and epicardial fibrosis, with relative sparing of the myocardium. Epicardial disease with sparing of the myocardium may explain the restrictive hemodynamics and relatively preserved systolic function present in these grafts at the time of re-OHT.

Entities:  

Mesh:

Year:  2008        PMID: 19017288     DOI: 10.1111/j.1399-3046.2008.01087.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Non-invasive detection of myocardial fibrosis in pediatric heart transplant recipients: The role of cardiovascular magnetic resonance.

Authors:  Jonathan H Soslow; Justin Godown
Journal:  Pediatr Transplant       Date:  2017-08

2.  Canonical Wnt/β-catenin signaling in epicardial fibrosis of failed pediatric heart allografts with diastolic dysfunction.

Authors:  Bo Ye; Yao Ge; Gregory Perens; Longsheng Hong; Haodong Xu; Michael C Fishbein; Faqian Li
Journal:  Cardiovasc Pathol       Date:  2012-04-02       Impact factor: 2.185

Review 3.  Heart Failure with Preserved Ejection Fraction in Children.

Authors:  Bibhuti Das; Shriprasad Deshpande; Jyothsna Akam-Venkata; Divya Shakti; William Moskowitz; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2022-08-17       Impact factor: 1.838

4.  Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease.

Authors:  Caitlin M Braitsch; Onur Kanisicak; Jop H van Berlo; Jeffery D Molkentin; Katherine E Yutzey
Journal:  J Mol Cell Cardiol       Date:  2013-10-17       Impact factor: 5.000

5.  Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.

Authors:  Seiko Ide; Eugenie Riesenkampff; David A Chiasson; Anne I Dipchand; Paul F Kantor; Rajiv R Chaturvedi; Shi-Joon Yoo; Lars Grosse-Wortmann
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-01       Impact factor: 5.364

6.  Native T1 mapping detects both acute clinical rejection and graft dysfunction in pediatric heart transplant patients.

Authors:  Devika P Richmann; Nyshidha Gurijala; Jason G Mandell; Ashish Doshi; Karin Hamman; Christopher Rossi; Avi Z Rosenberg; Russell Cross; Joshua Kanter; John T Berger; Laura Olivieri
Journal:  J Cardiovasc Magn Reson       Date:  2022-10-03       Impact factor: 6.903

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.